Hemophagocytic lymphohistiocytosis

Hematology

Volumn 10, Issue SUPPL. 1, 2005, Pages 104-107

  Janka, G E ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CORTICOSTEROID; CYCLOSPORIN A; DACLIZUMAB; ETOPOSIDE; THYMOCYTE ANTIBODY;

CLINICAL FEATURE; CYTOKINE RELEASE; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; EFFECTOR CELL; GENETIC ASSOCIATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; LABORATORY DIAGNOSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYMPTOM;

BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFECTION; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MUTATION;

EID: 29244439581     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330512331390087     Document Type: Review

References (20)

1. Farquhar JW, Claireaux AE. Familial haemophagocytic reticulosis. Arch Disease in Childhood 1952;27:519-525.
2. Henter JI, Elinder G, Soder O, Ost A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatrica Scandinavica 1991;80:428-435.
3. Dufourcq-Lagelouse R, Pastural E, Barrat FJ, Feldmann J, Le Deist F, Fischer A, De Saint Basile G. Genetic basis of hemophagocytic lymphohistiocytosis syndrome (Review). Int J Mol Med 1999;4:127-133.
4. Risdall RJ, McKenna RW, Nesbit ME, Krivit W, Balfour HH, Jr, Simmons RL, Brunning RD. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979;44:993-1002.
5. Reiner AP, Spivak JL. Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine (Baltimore) 1988;67:369-388.
6. Fisman DN. Hemophagocytic syndromes and infection. Emerging Infectious Diseases 2000;6:601-608.
7. Stephan JL, Zeller J, Hubert P. Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 1993b;11:451-456.
8. Ramanan AV, Baildam EM. Macrophage activation syndrome is hemophagocytic lymphohistiocytosis-need for the right terminology. J Rheumatol 2002;29: 1105; author reply 1105.
9. Janka G, Henter JI, Imashuku S. Clinical aspects and therapy of hemophagocytic lymphohistiocytosis. In: Weitzman S, Egeler RM, editors. Histiocytic Disorders of Children and Adults. Cambridge University Press; 2005. pp 353-379.
10. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathews PA, Henter JI, Bennett M, Fischer A, de Saint Basile G, Kumar V. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999;286:1957-1959.
11. Feldman J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, Lambert N, Quachee-Chardin M, Chedeville G, Tamary H, et al. Muncl3-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003;115:461-473.
12. Zur Stadt U, Schmidt S, Kasper B, Beutel K, Diler AS, Renter JI, Kabisch HI, Schneppenheim R, Nurnberg P, Janka G, Hennies HC. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11 gene. Hum Mol Genet 2005;14:827-834.
13. Schneider EM, Lorenz I, Muller-Rosenberger M, Steinbach G, Kron M, Janka-Schaub GE. Hemophagocytic lymphohistiocytosisis associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood 2002;100:2891-2898.
14. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Ped 1983;140:221-230.
15. Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, Viola S, Martini A. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Ped 2005;146:598-604.
16. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998;12:435-444.
17. Imashuku S, Kuriyama K, Teramura T, Ishii E, Kinugawa N, Kato M, Sako M, Hibi S. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 2001;19:2665-2673.
18. Stephan JL, Donadieu J, Ledeist F, Blanche S, Griscelli C, Fischer A. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood 1993;82:2319-2323.
19. Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D, Ladisch S, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and Bone Marrow Transplantation. Blood 2002;100:2367-2373.
20. Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Brit J Haematol 2004;124:4-14.